Connect with us

Survector (amineptine)

Amineptine (or SURVECTOR®) was mainly prescribed to treat major depressive disorder.


Class: Atypical, Tricyclic (TCA)

FDA Approval: International Only (Europe)

Dosage Forms: N/A

Biological Half-life: 0.8-1 hour

Side Effects: Dizziness, blurred vision, dry mouth, nausea, constipation, appetite changes, hyperhidrosis, sex drive changes

Routes of Administration: Oral

Pregnancy Category: N/A


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.